The DOI matches its Crossref record; 302 of the 305 references it cites were found in a registry or an index.
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
Open accessAbstract
Guidelines for the management of patients with invasive candidiasis and mucosal candidiasis were prepared by an Expert Panel of the Infectious Diseases Society of America. These updated guidelines replace the previous guidelines published in the 15 January 2004 issue of Clinical Infectious Diseases and are intended for use by health care providers who care for patients who either have or are at risk of these infections. Since 2004, several new antifungal agents have become available, and several new studies have been published relating to the treatment of candidemia, other forms of invasive candidiasis, and mucosal disease, including oropharyngeal and esophageal candidiasis. There are also recent prospective data on the prevention of invasive candidiasis in high-risk neonates and adults and on the empiric treatment of suspected invasive candidiasis in adults. This new information is incorporated into this revised document.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“In contrast with the 2009 Infectious Disease Society of America guidelines for the treatment of invasive candidiasis, in which echinocandins were recommended only for neutropenic patients and patients with previous exposure to antifungals (64)”
From Population-Based Active Surveillance for Culture-Confirmed Candidemia — Four Sites, United States, 2012–2016 (2019) · cites this paper as [64]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredIn the citing paper
“Consensus guidelines do suggest a combination of amphotericin B and flucytosine for some infection types such as Candida meningitis, endophthalmitis, and endocarditis.”
From Fungal Sepsis: Optimizing Antifungal Therapy in the Critical Care Setting (2011) · cites this paper as [110]
In the citing paper
“The IDSA guideline for invasive candidiasis recommends a 2-week treatment duration following clearance of Candida from the bloodstream and resolution of symptoms attributable to candidemia.”
From Fungal Sepsis: Optimizing Antifungal Therapy in the Critical Care Setting (2011) · cites this paper as [110]
In the citing paper
“Longer durations are recommended for persistent candidemia and for metastatic infection involving other sites (ie, CNS, bone, endocarditis, joint/ prosthetic joint infection).”
From Fungal Sepsis: Optimizing Antifungal Therapy in the Critical Care Setting (2011) · cites this paper as [110]
In the citing paper
“Treatment guidelines recommend step down to fluconazole for patients who have improved clinically after initial therapy with an echinocandin or amphotericin B and who are infected with an organism that is likely to be susceptible to fluconazole (eg, C albicans, C parapsilosis, and C tropicalis) or if there is documented susceptibility based on laboratory MIC testing.”
From Fungal Sepsis: Optimizing Antifungal Therapy in the Critical Care Setting (2011) · cites this paper as [110]
In the citing paper
“Therefore, the current guidelines suggest ophthalmologic examination for every patient with candidemia.”
From Fungal Sepsis: Optimizing Antifungal Therapy in the Critical Care Setting (2011) · cites this paper as [110]
In the citing paper
“Venous catheter infection and IC guidelines, including the current IDSA guidelines, recommend removal of any intravascular catheter that is positive for a fungal pathogen (ie, Candida) based on evidence from large retrospective and observational studies.”
From Fungal Sepsis: Optimizing Antifungal Therapy in the Critical Care Setting (2011) · cites this paper as [110]
In the citing paper
“Thus, the American Society of Infectious Diseases recommends that patients should use topical and oral azoles concurrently [38].”
From Treatment of Vulvovaginal Candidiasis—An Overview of Guidelines and the Latest Treatment Methods (2023) · cites this paper as [38]
In the citing paper
“They display in vitro fungicidal activity against most Candida species, attractive tolerability and pharmacokinetic profiles, and have been recommended as first line agents for invasive candidiasis (1–6).”
From Echinocandin resistance: an emerging clinical problem? (2014) · cites this paper as [6]
In the citing paper
“They display in vitro fungicidal activity against most Candida species, attractive tolerability and pharmacokinetic profiles, and have been recommended as first line agents for invasive candidiasis (1–6).”
From Echinocandin resistance: an emerging clinical problem? (2014) · cites this paper as [6]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wisplinghoff, H., Bischoff, T., Tallent, S. M., Seifert, H., Wenzel, R. P., & Edmond, M. B. (2004) · Clinical Infectious Diseases · doi:10.1086/421946 · Cited by 4,496
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
Pfaller, M. A., & Diekema, D. J. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00029-06 · Cited by 4,174 · cited 2×
“krusei [26, 81], but”
2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer
Hughes, W. T., Armstrong, D., Bodey, G. P., Bow, E. J., Brown, A. E., Calandra, T., Feld, R., Pizzo, P. A., Rolston, K. V. I., Shenep, J. L., et al. (2002) · Clinical Infectious Diseases · doi:10.1086/339215 · Cited by 1,964
Self-citationPosaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
Cornely, O. A., Maertens, J. A., Winston, D. J., Perfect, J. R., Ullmann, A. J., Walsh, T. J., HELFGOTT, D. C., Hołowiecki, J., Stockelberg, D., Goh, Y. T., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa061094 · Cited by 1,802
Self-citationComparison of Caspofungin and Amphotericin B for Invasive Candidiasis
Mora-Duarte, J., Betts, R., Rotstein, C., Colombo, A. L., Thompson-Moya, L., Smietana, J., Lupinacci, R., Sable, C., Kartsonis, N., & Perfect, J. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021585 · Cited by 1,380
Posaconazole or Fluconazole for Prophylaxis in Severe Graft-versus-Host Disease
Ullmann, A. J., Lipton, J. H., Vesole, D. H., Chandrasekar, P. H., Langston, A. A., Tarantolo, S., Greinix, H., de Azevedo, W. M., Reddy, V. S., Boparai, N., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa061098 · Cited by 1,339
Morrell, M., Fraser, V. J., & Kollef, M. H. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.9.3640-3645.2005 · Cited by 1,286
Liposomal Amphotericin B for Empirical Therapy in Patients with Persistent Fever and Neutropenia
Walsh, T. J., Finberg, R. W., Arndt, C., Hiemenz, J., Schwartz, C., Bodensteiner, D., Pappas, P., Seibel, N., Greenberg, R. N., Dummer, S., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903113401004 · Cited by 1,205
Self-citationGarey, K. W., Rege, M., Pai, M. P., Mingo, D. E., Suda, K. J., Turpin, R. S., & Bearden, D. T. (2006) · Clinical Infectious Diseases · doi:10.1086/504810 · Cited by 1,171
Attributable Mortality of Nosocomial Candidemia, Revisited
Gudlaugsson, O., Gillespie, S., Lee, K., Berg, J. V., Hu, J., Messer, S., Herwaldt, L., Pfaller, M., & Diekema, D. (2003) · Clinical Infectious Diseases · doi:10.1086/378745 · Cited by 1,140
Cited by
Sorted by citations
Items 901–1,000 of 1,020
Peron, I. H., Reichert‐Lima, F., Busso-Lopes, A. F., Nagasako, C. K., Lyra, L., Moretti, M. L., & Schreiber, A. Z. (2016) · PLoS ONE · doi:10.1371/journal.pone.0158126 · Cited by 38
Epidemiology of candidemia and impact of infectious disease consultation on survival and care
Mohr, A., Simon, M., Joha, T., Hanses, F., Salzberger, B., & Hitzenbichler, F. (2020) · Infection · doi:10.1007/s15010-020-01393-9 · Cited by 37
Decreasing rates of invasive candidiasis in pediatric hospitals across the United States.
Fisher, B. T., Ross, R. K., Localio, A. R., Prasad, P. A., & Zaoutis, T. E. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/cit679 · Cited by 35
Chong, Y., Ito, Y., Kamimura, T., Shimoda, S., Miyamoto, T., Akashi, K., Yakushiji, H., & Shimono, N. (2012) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-012-0412-9 · Cited by 35
Mikołajewska, A., Schwartz, S., & Ruhnke, M. (2011) · Mycoses · doi:10.1111/j.1439-0507.2010.01961.x · Cited by 35
Alothman, A. F., Al-Musawi, T., Al-Abdely, H. M., Salman, J. A., Almaslamani, M., Yared, N., Butt, A. A., Raghubir, N., Morsi, W. E., & Althaqafi, A. (2013) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2013.08.002 · Cited by 36
Impact of First-Line Antifungal Agents on the Outcomes and Costs of Candidemia
Ha, Y. E., Peck, K. R., Joo, E., Kim, S., Jung, S., Chang, H., Park, K. H., & Han, S. H. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06258-11 · Cited by 36
Epidemiology of Candida isolates from Intensive Care Units in Colombia from 2010 to 2013
Motoa, G., Muñoz, J. S., Oñate, J., Pallares, C., Hernández, C., & Villegas, M. V. (2016) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2016.02.006 · Cited by 35
Treatment of Infection in Burn Patients
Cambiaso‐Daniel, J., Gallagher, J. J., Norbury, W. B., Finnerty, C. C., Herndon, D. N., & Culnan, D. M. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-47661-4.00011-3 · Cited by 35
Andrew, E. C., Curtis, N. C., Coghlan, B., Cranswick, N., & Gwee, A. (2018) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13521 · Cited by 35
Candida lusitaniae in Kuwait: Prevalence, antifungal susceptibility and role in neonatal fungemia
Khan, Z., Ahmad, S., Al‐Sweih, N., Khan, S. I., & Joseph, L. (2019) · PLoS ONE · doi:10.1371/journal.pone.0213532 · Cited by 35
Sow, D., Fall, B., Ndiaye, M., Ba, B. S., Sylla, K., Tine, R. C. K., Lô, A. C., Abiola, A., Wade, B., Dieng, T., et al. (2015) · Mycopathologia · doi:10.1007/s11046-015-9905-2 · Cited by 35
From Biology to Drug Development: New Approaches to Combat the Threat of Fungal Biofilms
Pierce, C. G., Srinivasan, A., Ramasubramanian, A. K., & Lopez-Ribot, J. L. (2015) · Microbiology Spectrum · doi:10.1128/microbiolspec.mb-0007-2014 · Cited by 36
Li, F., Wu, L., Cao, B., Zhang, Y., Li, X., & Liu, Y. (2013) · BMC Infectious Diseases · doi:10.1186/1471-2334-13-353 · Cited by 35
Hospital use of systemic antifungal drugs: a multi-center surveillance update from Germany
Gross, B. N., Steib–Bauert, M., Kern, W. V., Knoth, H., Borde, J., Krebs, S., Hug, M. J., Rothe, U., Maier, L., & de With, K. (2015) · Infection · doi:10.1007/s15010-015-0742-5 · Cited by 35
Cardiac toxicity of some echinocandin antifungals
Stover, K. R., Farley, J. M., Kyle, P. B., & Cleary, J. D. (2013) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2013.829036 · Cited by 35
Kourkoumpetis, T. K., Velmahos, G. C., Ziakas, P. D., Tampakakis, E., Manolakaki, D., Coleman, J. J., & Mylonakis, E. E. (2010) · Mycopathologia · doi:10.1007/s11046-010-9369-3 · Cited by 35
Aspergillus Vertebral Osteomyelitis in Immunocompetent Hosts: Role of Triazole Antifungal Therapy
STUDEMEISTER, A. E., & Stevens, D. A. (2010) · Clinical Infectious Diseases · doi:10.1093/cid/ciq039 · Cited by 35
Autmizguine, J., Hornik, C. P. V., Benjamin, D. K., Brouwer, K. L. R., Hupp, S. R., Cohen‐Wolkowiez, M., & Watt, K. (2016) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000001268 · Cited by 35
Self-citationPhytol-Loaded Solid Lipid Nanoparticles as a Novel Anticandidal Nanobiotechnological Approach
Lima, T. L. C., de Souza, L. B. F. C., Tavares-Pessoa, L. C. S., Silva, A. M. D. S., Cavalcante, R. S., de Araujo-Junior, R. F., Cornélio, A. M., Fernandes‐Pedrosa, M. D. F., Chaves, G. M., & da Silva-Júnior, A. A. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12090871 · Cited by 34
Current knowledge of vertebral osteomyelitis: a review
Zou, X., Li, X., He, K., Song, Q., & Yin, R. (2024) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-024-04983-9 · Cited by 34
Potential impact of rapid diagnostic tests on improving antimicrobial use
Tenover, F. C. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05827.x · Cited by 34
Guarascio, A. J., Slain, D., McKnight, R., Petros, K. O., Parker, J. E., Wilson, A. M., Defazio, C. M., & Sarwari, A. R. (2012) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-012-9712-5 · Cited by 34
Antifungal Activity of Geldanamycin Alone or in Combination with Fluconazole Against Candida species
Zhang, J., Liu, W. Y., Tan, J., Sun, Y., Wan, Z., & Li, R. (2013) · Mycopathologia · doi:10.1007/s11046-012-9612-1 · Cited by 34
Clinical Aspects of Invasive Candidiasis in Solid Organ Transplant Recipients
Grossi, P. (2009) · Drugs · doi:10.2165/11315510-000000000-00000 · Cited by 34
Infections in Intestinal and Multivisceral Transplant Recipients
Timpone, J. G., Girlanda, R., Rudolph, L., & Fishbein, T. (2013) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2013.02.012 · Cited by 34
Tang, X., Hua, Y., Guan, Q., & Yuan, C. (2016) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-015-2574-8 · Cited by 36
Pieralli, F., Corbo, L., Torrigiani, A., Mannini, D., Antonielli, E., Mancini, A., Corradi, F., Arena, F., Pignone, A. M., Morettini, A., et al. (2017) · Internal and Emergency Medicine · doi:10.1007/s11739-017-1627-7 · Cited by 34
AFM combined to ATR-FTIR reveals Candida cell wall changes under caspofungin treatment
Quilès, F., Accoceberry, I., Couzigou, C., Francius, G., Noël, T., & El‐Kirat‐Chatel, S. (2017) · Nanoscale · doi:10.1039/c7nr02170d · Cited by 34
O’Leary, R., Einav, S., Léone, M., Madách, K., Martin, C., & Martín‐Loeches, I. (2017) · Journal of Hospital Infection · doi:10.1016/j.jhin.2017.11.020 · Cited by 34
Sbrana, F., Sozio, E., Bassetti, M., Ripoli, A., Pieralli, F., Azzini, A. M., Morettini, A., Nozzoli, C., Merelli, M., Rizzardo, S., et al. (2018) · Internal and Emergency Medicine · doi:10.1007/s11739-017-1783-9 · Cited by 34
Dong, S., Shi, H., Zhang, X., Chen, X., Cao, D., Mao, C., Gao, X., & Wang, L. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s156815 · Cited by 34
Chen, C., Cheng, A., Tien, F., Lee, P., Tien, H., Sheng, W., & Chen, Y. (2019) · BMC Infectious Diseases · doi:10.1186/s12879-019-4260-4 · Cited by 35
Zeng, Z., Ding, Y., Tian, G., Yang, K., Deng, J. M., Li, G., & Liu, J. (2020) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-020-00798-3 · Cited by 34
Shirazi, F., & Kontoyiannis, D. P. (2015) · Virulence · doi:10.1080/21505594.2015.1027479 · Cited by 35
Candida Speciation, Antifungal Treatment and Adverse Events in Pediatric Invasive Candidiasis
Palazzi, D. L., Arrieta, A. C., Castagnola, E., Halasa, N., Hubbard, S., Brozovich, A., Fisher, B. T., & Steinbach, W. J. (2014) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000000431 · Cited by 34
Candidemia in Burn Patients: Figures and Facts
Pedrosa, A. F., & Rodrigues, A. G. (2011) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0b013e3181f2d4fb · Cited by 34
Pfaller, M. A., Boyken, L. B., Hollis, R. J., Kroeger, J. S., Messer, S. A., Tendolkar, S., & Diekema, D. J. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.02437-10 · Cited by 34
Bustamante, B., Martins, M. A., Bonfietti, L. X., Szeszs, M. W., Jacobs, J. A., García, C., & Melhem, M. D. S. C. (2014) · Journal of Medical Microbiology · doi:10.1099/jmm.0.071167-0 · Cited by 34
Recommendations for the management of candidemia in children in Latin America
Santolaya, M. E., Telles, F. D. Q., Matute, T. A., Colombo, A. L., Zurita, J., Tiraboschi, I. N., Cortés, J. A., Thompson-Moya, L., Guzmán-Blanco, M., Sifuentes‐Osornio, J., et al. (2013) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2013.05.010 · Cited by 37
Biowaiver Monograph for Immediate-Release Solid Oral Dosage Forms: Fluconazole
Charoo, N. A., Cristofoletti, R., Graham, A., Lartey, P. A., Abrahamsson, B., Groot, D. W., Kopp, S., Langguth, P., Polli, J. E., Shah, V. P., et al. (2014) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24181 · Cited by 34
Rational Use of Antimicrobials in Patients with Severe Acute Pancreatitis
Waele, J. J. D. (2011) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0031-1275529 · Cited by 34
Ng, T. S., Desa, M. N. M., Sandai, D. A., Chong, P. P., & Than, L. T. L. (2015) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2015.09.004 · Cited by 38
Geng, L., Xu, M., Yu, L., Li, J., Zhou, Y., Wang, Y., & Chen, J. (2016) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2016.3353 · Cited by 34
Bonfietti, L. X., Szeszs, M. W., Chang, M. R., Martins, M. A., Pukinskas, S. R. B. S., Nunes, M. O., Pereira, G. H., Paniago, A. M. M., Purisco, S. U., & Melhem, M. D. S. C. (2012) · Mycopathologia · doi:10.1007/s11046-012-9566-3 · Cited by 33
Alvarez-Rueda, N., Fleury, A., Morio, F., Pagniez, F., Gastinel, L. N., & Pape, P. L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021239 · Cited by 33
Aguilar‐Guisado, M., Martín‐Peña, A., Espigado, I., de Pipaón, M. R. P., Falantes, J. F., la Cruz, F. D., & Cisneros, J. M. (2011) · Haematologica · doi:10.3324/haematol.2011.049999 · Cited by 33
Interactions of Yeasts, Moulds, and Antifungal Agents
Hall, G. S. (2011) · Humana Press eBooks · doi:10.1007/978-1-59745-134-5 · Cited by 33
Dudiuk, C., Macedo, D., Leonardelli, F., Theill, L., Cabeza, M. S., Gamarra, S. P., & García‐Effrón, G. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02644-16 · Cited by 33
Jung, P., Mischo, C. E., Gunaratnam, G., Spengler, C., Becker, S. L., Hube, B., Jacobs, K., & Bischoff, M. (2020) · Virulence · doi:10.1080/21505594.2020.1836902 · Cited by 35
Scoullar, M. J. L., Boeuf, P., Peach, E., Fidelis, R., Tokmun, K., Melepia, P. U., Elijah, A., Bradshaw, C. S., Fehler, G., Siba, P. M., et al. (2021) · Emerging infectious diseases · doi:10.3201/eid2703.201783 · Cited by 33
The Epidemiology of Invasive Candidiasis
Pfaller, M. A., & Diekema, D. J. (2014) · ASM Press eBooks · doi:10.1128/9781555817176.ch29 · Cited by 33
Glycerophosphocholine Utilization by Candida albicans
Bishop, A. C., Ganguly, S., Solis, N. V., Cooley, B., Jensen‐Seaman, M. I., Filler, S. G., Mitchell, A. P., & Patton, J. L. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.505735 · Cited by 33
Self-citationPfaller, M. A., Boyken, L. B., Hollis, R. J., Kroeger, J. S., Messer, S. A., Tendolkar, S., & Diekema, D. J. (2010) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2010.01.001 · Cited by 33
Radiotracers for fungal infection imaging
Lupetti, A., de Boer, M. G. J., Erba, P. A., Campa, M., & Nibbering, P. H. (2010) · Medical Mycology · doi:10.3109/13693786.2010.508188 · Cited by 33
Invasive candidiasis: update on current pharmacotherapy options and future perspectives
Tragiannidis, A., Tsoulas, C., Kerl, K., & Groll, A. H. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2013.805204 · Cited by 34
DiDone, L., Oga, D., & Krysan, D. J. (2011) · Yeast · doi:10.1002/yea.1860 · Cited by 33
Candida spp. bloodstream infection: influence of antifungal treatment on outcome
Ortega, M., Marco, F., Soriano, À., Almela, M., Martínez, J. A., Pitart, C., & Mensa, J. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp495 · Cited by 33
Fungal Infections in Transplant and Oncology Patients
Person, A. K., Kontoyiannis, D. P., & Alexander, B. D. (2011) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2010.11.013 · Cited by 33
Ten-year review of invasive Candida infections in a tertiary care center in Saudi Arabia
Omrani, A. S., Makkawy, E. A., Baig, K., Baredhwan, A. A., Almuthree, S. A., Elkhizzi, N. A., & Albarrak, A. M. (2014) · Saudi Medical Journal · doi:10.15537/1658-3175.6005 · Cited by 33
Peterson, J. F., Pfaller, M. A., Diekema, D. J., Rinaldi, M. G., Riebe, K. M., & Ledeboer, N. A. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.02517-10 · Cited by 33
Rodrigues, C. F., Gonçalves, B., Rodrigues, M. E., Silva, S. M., Azeredo, J., & Henriques, M. (2017) · Mycopathologia · doi:10.1007/s11046-017-0135-7 · Cited by 33
Rosana, Y., Yasmon, A., & Lestari, D. C. (2015) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000123 · Cited by 33
Chen, X.-C., Xu, J., & Wu, D.-P. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1523 · Cited by 32
Candidemia y candidiasis invasora en el adulto. Formas clínicas y tratamiento
Cervera, C. (2012) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2012.02.003 · Cited by 35
Zhong, L., Dong, Z., Liu, F., Li, H., Tang, K., Zheng, C., Wang, L., Zhang, K., Cai, J., Zhou, H., et al. (2022) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-022-00538-y · Cited by 34
Urinary tract infection in children
Alsaywid, B. S., Alyami, F. A., Alqarni, N., Neel, K. F., Almaddah, T. O., Abdulhaq, N. M., Alajmani, L., Hindi, M. O., Alshayie, M., Alsufyani, H. M., et al. (2023) · Urology Annals · doi:10.4103/ua.ua_147_22 · Cited by 32
Hu, Q., Li, T., Yang, J., Peng, Y., Liu, Q., & Liu, N. (2023) · BMC Oral Health · doi:10.1186/s12903-023-03484-z · Cited by 32
Antifungal Susceptibility of Bloodstream Candida Isolates in Sfax Hospital: Tunisia
Sellami, A., Sellami, H., Néji, S., Makni, F., Abbes, S., Cheikhrouhou, F., Chelly, H., Bouaziz, M., Hammami, B., Jemâa, M. B., et al. (2010) · Mycopathologia · doi:10.1007/s11046-010-9388-0 · Cited by 32
Discrimination of Candida species by paper spray mass spectrometry
Hamid, A. M., Wei, P., Jarmusch, A. K., Pirro, V., & Cooks, R. G. (2014) · International Journal of Mass Spectrometry · doi:10.1016/j.ijms.2014.09.013 · Cited by 32
INVASIVE CANDIDIASIS IN NON-HEMATOLOGICAL PATIENTS.
Mikulska, M., Bassetti, M., Ratto, S., & Viscoli, C. (2011) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2011.007 · Cited by 32
EUCAST and CLSI: Working Together Towards a Harmonized Method for Antifungal Susceptibility Testing
Espinel‐Ingroff, A., Cuenca‐Estrella, M., & Cantón, E. (2013) · Current Fungal Infection Reports · doi:10.1007/s12281-012-0125-7 · Cited by 32
Imtiaz, T., Lee, K. K., Munro, C. A., MacCallum, D. M., Shankland, G. S., Johnson, E. M., MACGREGOR, M. S., & Bal, A. M. (2012) · Journal of Medical Microbiology · doi:10.1099/jmm.0.045047-0 · Cited by 32
Incidence and predictors of invasive candidiasis associated with candidaemia in children
Festekjian, A., & Neely, M. N. (2009) · Mycoses · doi:10.1111/j.1439-0507.2009.01785.x · Cited by 32
Laboratory approach for diagnosis of candidiasis through ages
Deorukhkar, S. C., & Saini, S. (2014) · Cited by 32
Sasso, M., Roger, C., Sasso, M., Poujol, H., Barbar, S. D., Lefrant, J., & Lachaud, L. (2017) · Mycoses · doi:10.1111/myc.12661 · Cited by 32
Brilhante, R. S. N., Correia, E. E. M., Guedes, G. M. D. M., de Oliveira, J. S., Castelo‐Branco, D. D. S. C. M., Cordeiro, R. D. A., Pinheiro, A. D. Q., Chaves, L. J. Q., Neto, W. D. A. P., Sidrim, J. J. C., et al. (2018) · Mycoses · doi:10.1111/myc.12763 · Cited by 32
Mencarini, J., Mantengoli, E., Tofani, L., Riccobono, E., Fornaini, R., Bartalesi, F., Corti, G., Farese, A., Pecile, P., Boni, L., et al. (2018) · Infection · doi:10.1007/s15010-018-1139-z · Cited by 32
Gao, Z., Li, X., Du, Y., Peng, Y., Wu, W., & Zhou, Y. (2018) · Medical Science Monitor · doi:10.12659/msm.909168 · Cited by 32
Nosocomial Infections and Ventilator-Associated Pneumonia in Cancer Patients
Divatia, J., Pulinilkunnathil, J. G., & Myatra, S. N. (2019) · Springer eBooks · doi:10.1007/978-3-319-74588-6_125 · Cited by 32
Zheng, Y., Xie, T., Wu, L., Liu, X.-Y., Zhu, L. Y., Chen, Y., Mao, E., Han, L., Chen, E., & Yang, Z. (2021) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-021-00441-y · Cited by 32
Bartolo, C., Hall, V. G., Friedman, N. D., Lanyon, C., Fuller, A., Morrissey, C. O., & Athan, E. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-05982-3 · Cited by 32
Montagna, M. T., Lovero, G., Coretti, C., Martinelli, D., Giglio, O. D., Iatta, R., Balbino, S., Rosato, A., & Caggiano, G. (2015) · BMC Microbiology · doi:10.1186/s12866-015-0442-4 · Cited by 32
Halawa, A., Henry, P. D., & Sarubbi, F. A. (2010) · Mycoses · doi:10.1111/j.1439-0507.2010.01866.x · Cited by 32
Fungal infections in immunocompromised patients
Sganga, G. (2011) · Mycoses · doi:10.1111/j.1439-0507.2011.02134.x · Cited by 32
Luzzati, R., Cavinato, S., Deiana, M. L., Rosin, C., Maurel, C., & Borelli, M. (2014) · Aging Clinical and Experimental Research · doi:10.1007/s40520-014-0251-x · Cited by 32
Pereira, A. M. S., Hernandes, C., Pereira, S. I. V., Bertoni, B. W., França, S. D. C., Pereira, P. S., & Contini, S. H. T. (2014) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2014.10.023 · Cited by 32
Denardi, L. B., Mario, D. A. N., Loreto, É. S., Santúrio, J. M., & Alves, S. H. (2015) · Brazilian Journal of Microbiology · doi:10.1590/s1517-838246120120442 · Cited by 32
Won, E. J., Shin, J. H., Lee, K., Kim, M., Lee, H. S., Park, Y.-J., Joo, M. Y., Kim, S. H., Shin, M., Suh, S., et al. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.00945-13 · Cited by 32
Invasive fungal infections in newborns and current management strategies
Hundalani, S. G., & Pammi, M. (2013) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2013.811925 · Cited by 32
Li, Y., Du, M., Chen, L., Liu, Y., & Liang, Z. (2016) · Mycopathologia · doi:10.1007/s11046-016-9997-3 · Cited by 32
Bordallo-Cardona, M. Á., Escribano, P., de la Pedrosa, E. G. G., Marcos-Zambrano, L. J., Cantón, R., Bouza, E., & Guinea, J. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01542-16 · Cited by 32
Fungal and Parasitic CNS Infections
SINGHI, P. D., & Saini, A. G. (2017) · The Indian Journal of Pediatrics · doi:10.1007/s12098-017-2487-x · Cited by 32
Lichtenstern, C., Hochreiter, M., Zehnter, V. D., Brenner, T., Hofer, S., Mieth, M., Büchler, M. W., Martin, E., Weigand, M. A., Schemmer, P., et al. (2013) · Mycoses · doi:10.1111/myc.12041 · Cited by 31
Do all candidemic patients need an ophthalmic examination?
Vinikoor, M. J., Zoghby, J., Cohen, K. L., & Tucker, J. D. (2013) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2012.12.014 · Cited by 31
Kamikawa, Y., Mori, Y., Nagayama, T., Fujisaki, J., Hirabayashi, D., Sakamoto, R., Hamada, T., & SUGIHARA, K. (2014) · BMC Oral Health · doi:10.1186/1472-6831-14-14 · Cited by 31
How to select an antifungal agent in critically ill patients
Dimοpoulos, G., Antonopoulou, A., Armaganidis, A., & Vincent, J. (2013) · Journal of Critical Care · doi:10.1016/j.jcrc.2013.04.006 · Cited by 33
Chen, L.-Y., Liao, S.-Y., Kuo, S., Chen, S.-J., Chen, Y., Wang, F.-D., Yang, S.-P., & Fung, C. (2011) · Journal of Hospital Infection · doi:10.1016/j.jhin.2010.12.007 · Cited by 31
Zhang, W., Wu, S., Wang, X., Gao, Y., & Yan, Z. (2021) · Mycoses · doi:10.1111/myc.13371 · Cited by 31
Mahmoud, D. E., Faraag, A. H. I., & Abu El-Wafa, W. M. (2021) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-021-03158-4 · Cited by 26
Metadata
- Authors
- Pappas, P. G., Kauffman, C. A., Andes, D., Benjamin, D. K., Calandra, T. F., Edwards, J. E., Filler, S. G., Fisher, J. F., Kullberg, B.-J., Zeichner, L. O., Reboli, A. C., Rex, J. H., Walsh, T. J., & Sobe, J. D.
- Affiliations
- University of Alabama at Birmingham (US)
- University of Michigan (US)
- University of Wisconsin–Madison (US)
- Duke Medical Center (US)
- Centre Hospitalier Universitaire Vaudois (CH)
- University of California, Los Angeles (US)
- Augusta University (US)
- Radboud University Nijmegen (NL)
- University of Texas at Houston, Houston
- Cooper University Hospital (US)
- AstraZeneca (United Kingdom) (GB)
- National Cancer Institute (US)
- Wayne State University (US)
- Corresponding author
- Pappas, Peter G.
- ORCID
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-03-01
- Volume
- 48
- Issue
- 5
- Pages
- 503-535
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- PMC
- PMC7294538
- OpenAlex
- W2150428940
- Cited by
- 3,191
- References
- 305
- Citations by year
- 2026: 23 · 2025: 41 · 2024: 49 · 2023: 55 · 2022: 65 · 2021: 121 · 2020: 155 · 2019: 149 · 2018: 149 · 2017: 195 · 2016: 226 · 2015: 327 · 2014: 312 · 2013: 311 · 2012: 319
- FWCI
- 230.85
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- SERVAL (Université de Lausanne) (publishedVersion, other-oa)
- PubMed Central (acceptedVersion)
- reroDoc Digital Library (submittedVersion)
- IRIS (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Funders
- Amgen
- Pfizer
- AstraZeneca
- Gilead Sciences
- Infectious Diseases Society of America
- Astellas Pharma
- Basilea Pharmaceutica
- National Institutes of Health
- Centers for Disease Control and Prevention
- Pfizer Pharmaceuticals
- National Cancer Institute (Z01SC006830)
- National Institute of Child Health and Human Development
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Health Sciences › Medicine › Ophthalmology › Ocular Infections and Treatments
- Keywords
- invasive candidiasis, mucosal candidiasis, candidemia, oropharyngeal candidiasis, esophageal candidiasis, antifungal agents, empirical antifungal therapy, high-risk infants, high-risk adults
- MeSH terms
- Antifungal Agents, Candidiasis, Humans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
